2003
DOI: 10.1007/s11926-003-0085-6
|View full text |Cite
|
Sign up to set email alerts
|

Bisphosphonate mechanism of action

Abstract: The nitrogen-containing bisphosphonates (N-BPs), alendronate and risedronate, are the only pharmacologic agents shown to prevent spine and nonvertebral fractures associated with postmenopausal and glucocorticoid-induced osteoporosis. At the tissue level, this is achieved through osteoclast inhibition, which leads to reduced bone turnover, increased bone mass, and improved mineralization. The molecular targets of bisphosphonates (BPs) have recently been identified. This review will discuss the mechanism of acti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
98
0
4

Year Published

2004
2004
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 165 publications
(108 citation statements)
references
References 80 publications
3
98
0
4
Order By: Relevance
“…Its dependence on increased blood flow explains why the process responds to rest (which will help to reduce it) and, possibly, to bisphosphonates [37,38]. Bisphosphonates inhibit the action of osteoclasts, although not by impacting directly on the OPG/RANK-L system [39,40], but their use also reduces local blood flow in other conditions associated with regional hyperaemia [41,42]. If the long-term benefit of bisphosphonates is ever proven in the Charcot foot, it is as likely to be the result of this effect on local circulation as on their inhibition of bone resorption by osteoclasts.…”
Section: Opg/rank-l In Charcot Footmentioning
confidence: 99%
“…Its dependence on increased blood flow explains why the process responds to rest (which will help to reduce it) and, possibly, to bisphosphonates [37,38]. Bisphosphonates inhibit the action of osteoclasts, although not by impacting directly on the OPG/RANK-L system [39,40], but their use also reduces local blood flow in other conditions associated with regional hyperaemia [41,42]. If the long-term benefit of bisphosphonates is ever proven in the Charcot foot, it is as likely to be the result of this effect on local circulation as on their inhibition of bone resorption by osteoclasts.…”
Section: Opg/rank-l In Charcot Footmentioning
confidence: 99%
“…This effect was noted early in therapy. [28][29][30][31] However, the occurrence of osteonecrosis of the jaws with the use of intravenous bisphosphonates is of concern to the dental community. After initial observations by Wang at the University of California,osteonecrosis of the jaws is seen to occur more commonly in the mandible but has also been reported in the maxilla, and appears to be highly associated with periodontitis, other oral infections, and extraction of the affected teeth in majority of the reported cases.…”
mentioning
confidence: 99%
“…Assim, os bisfosfonatos são um grupo de drogas potentes que atuam na inibição da atividade osteoclás-tica, onde quer que ela seja necessária (33) . Isto explica a variedade de suas indicações.…”
Section: Discussionunclassified